ERIN COX: Open Payments
NPI 1407213846 · LEAWOOD, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$78 in 4 payments from 4 companies in 2025. Trend: 2023 $1,109 · 2024 $253 · 2025 $78
Food & beverage: $78
| Company | Payments | Amount |
|---|---|---|
| Genentech USA, Inc. | 1 | $26 |
| Smith+Nephew, Inc. | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Melinta Therapeutics, LLC | 1 | $14 |
Products named: Xolair, COLLAGENASE SANTYL, Rezzayo.
Industry payments across KS — which companies pay providers there.
